Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Recruiting now · Not applicable
Conditions studied: Heart Failure With Reduced Ejection Fraction, Cardiogenic Shock
In brief
This study aims to compare the impact of hemodynamic monitoring using pulmonary artery catheter (PAC) on survival and inotropic agent reduction in patients with cardiogenic shock caused by heart failure with reduced ejection fraction (HFrEF). The investigators also intend to compare the difference in long-term survival rates among patients who have recovered from cardiogenic shock due to HFrEF, based on the timing of initiation of beta-blocker treatment.
Key facts
- Study ID
- NCT06078436
- Run by
- Min-Seok Kim
- People needed
- 160
- Starts
- 2024-01-01
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2024-01-05
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults age 19 and above ( no age limit for elderly )
- Patients with cardiogenic shock requiring intensive care monitoring in ICU
- Patients eligible for oral medication administration
- Patients who have provided research participation consent through a written informed consent form
You may not qualify if…
- Unwilling or unable to obtain informed consent by the participant or substitute decision maker
- Patients with mechanical circulatory support at the time of screening
- Patients with acute coronary syndrome
- Patients with severe valvular heart disease requiring emergent percutaneous procedures or surgery
- Known hypersensitivity to beta-blockers
- Patients with a history of bronchospasm or asthma
- Patients with bradycardia or second or third-degree atrioventricular block
- Patients with sick sinus syndrome, including sinoatrial block
- Patients with untreated pheochromocytoma
- Patients currently undergoing de-sensitization therapy
- Patients who are currently pregnant, postpartum period within 30 days or breast-feeding
Where it is running
- Asan Medical Center — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.